Jefferies raises Charles River Labs stock price target on cost efficiency outlook
Jefferies raises Charles River Labs stock price target on cost efficiency outlook Investing.com UK
Covered in this story
What has happened since
- Charles River Laboratories is up 6.1% since this was published, 22 days ago.
Price move measured from the close nearest publication to the latest quote.
Tracked from this story
Jefferies’s $340 target on $CRL is on the record and being tracked to Sep 2027 (12-month default), scored on the close that day.
Jefferies’s track record →Analyst targets on Charles River Laboratories
- JPMorgan: $266 → $310 by Aug 2027 · Overweight via Investing.com
- Evercore ISI: $261 → $300 by Aug 2027 · Outperform via Investing.com
- CLSA: $220 → $219 by Jul 2027 · Hold via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $CRL yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Charles River Laboratories →Summary aggregated from Investing.com UK's public RSS feed. The full reporting belongs to Investing.com UK — please read it on their site.